首页 > 最新文献

中国中西医结合杂志最新文献

英文 中文
Chinese and western medicine study on vigorous heat of Qi and Ying type in severe COVID-19 patients 新型冠状病毒肺炎重症患者气盈型正热的中西医结合研究
Pub Date : 2020-01-01 DOI: 10.7661/j.cjim.20200530.234
Miaomiao Zhang
Vigorous heat of Qi and Ying type in severe coronavirus disease 2019 COVID-19 patients mainly shows heat syndrome in Qi thermal perturbation syndrome in heart and Ying and stasis heat syndrome in blood it mainly shows dyspnea and or hypoxemia in Western medicine severe cases can be rapidly develop for acute respiratory distress syndrome sepsis shock blood coagulation dysfunction and multiple organ failure and so on. There is a consistency between the vigorous heat of Qi and Ying type in COVID 19 and sepsis in clinical manifestations development and treatment which provides theoretical basis for the treatment of severe COVID19 patients with vigorous heat of Qi and Ying type.
2019冠状病毒感染症(COVID-19)重症患者气热盈型主要表现为心气热摄证和血盈瘀热证,西药主要表现为呼吸困难和/或低氧血症,严重者可迅速发展为急性呼吸窘迫综合征败血症休克凝血功能障碍及多器官功能衰竭等。新型冠状病毒肺炎的气热盈型与败血症在临床表现、发展及治疗上具有一致性,为新型冠状病毒肺炎气热盈型重症患者的治疗提供了理论依据。
{"title":"Chinese and western medicine study on vigorous heat of Qi and Ying type in severe COVID-19 patients","authors":"Miaomiao Zhang","doi":"10.7661/j.cjim.20200530.234","DOIUrl":"https://doi.org/10.7661/j.cjim.20200530.234","url":null,"abstract":"Vigorous heat of Qi and Ying type in severe coronavirus disease 2019 COVID-19 patients mainly shows heat syndrome in Qi thermal perturbation syndrome in heart and Ying and stasis heat syndrome in blood it mainly shows dyspnea and or hypoxemia in Western medicine severe cases can be rapidly develop for acute respiratory distress syndrome sepsis shock blood coagulation dysfunction and multiple organ failure and so on. There is a consistency between the vigorous heat of Qi and Ying type in COVID 19 and sepsis in clinical manifestations development and treatment which provides theoretical basis for the treatment of severe COVID19 patients with vigorous heat of Qi and Ying type.","PeriodicalId":10107,"journal":{"name":"中国中西医结合杂志","volume":"47 1","pages":"864-867"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73090206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Effects of Tengmei Decoction on the PPAR-y/NF-KB Signaling Pathway in Synovium of Collagen-in- duced Arthritis Rats]. [藤梅汤对胶原蛋白诱导关节炎大鼠滑膜PPAR-y/NF-KB信号通路的影响]。
Pub Date : 2017-04-01
Jie Wang, Ya-Nan Wang, Yan Lu, Yi Chen, Wen Gu, Kang Wang, Zhi-Ming Shen, Xiang-Wei Bu, Hong-Hong Zhang, Jian-Ping Zhang, Qing-Yi Lu, Feng-Xian Meng

Objective To observe the effects of Tengmei Decoction (TMD) on the expressions of peroxisome proliferator activated receptor gamma (PPARγ) , nuclear factor kappa B (NF-κB) , and IL- 17 in synovium of collagen-induced arthritis (CIA) rats, and to study its molecular mechanismpf. inhibi- ting synovial immune inflammatory injuries. Methods CIA model was established in Sprague-Dawley rats. Successfully modeled rats were randomly divided into the model group, the positive drug ,oup, high and low dose TMD groups, 6 in each group. Besides, a normal group was set up (n =6). Deionized water (10 mL . kg⁻¹ . d⁻¹) was administrated to rats in the normal group and the model group by gastro- gavage. Leflunomide (1. 87 mg . kg ⁻¹ . d ⁻¹) was administrated to rats in the positive drug group by gastro- gavage. TMD (31. 8 g crude drugs . kg ⁻¹ . d ⁻¹ and 15. 9 g crude drugs . kg ⁻¹ . d ⁻¹) was administrated to rats in high and low dose TMD groups respectively by gastrogavage. The intervention lasted for 12 suc- cessive weeks. Protein and mRNA levels of PPARy, P65, and IL-17 were detected at the end of intervention. Results Compared with the normal group, mRNA and protein expression levels of PPARγ, P65, and IL-17 were up-regulated in the model group (P <0. 01). Compared with the model group, PPARγ pro- tein expression level was up-regulated, mRNA and protein expression levels of P65 and IL-17 were down-regulated in high dose TMD group (P <0. 01). mRNA and protein expression levels of PPARγ were up-regulated, mRNA and protein expression levels of P65 and IL-17 were down-regulated in the positive drug group and low dose TMD group (P <0. 01). Conclusions TMD could ameliorate pathological damage of joint synovium , and inhibit expressions of immune inflammatory factors.

目的观察藤梅汤(TMD)对胶原性关节炎(CIA)大鼠滑膜过氧化物酶体增殖物激活受体γ (PPARγ)、核因子κB (NF-κB)、IL- 17表达的影响,并探讨其分子机制。抑制滑膜免疫炎性损伤。方法建立Sprague-Dawley大鼠CIA模型。将成功造模的大鼠随机分为模型组、阳性药物组、对照组、TMD高、低剂量组,每组6只。另设正常组(n =6)。去离子水(10ml)。公斤⁻¹。D - 1(毒血症)给药于正常组和模型组大鼠。Leflunomide(1。87毫克。Kg⁻(⁻)给药阳性组大鼠灌胃给药。TMD(31。生药8克。Kg⁻(⁻)D - 1和15。9克生药。Kg⁻(⁻)d - 1)分别给TMD高、低剂量组大鼠灌胃。干预持续12周。在干预结束时检测pparty、P65和IL-17的蛋白和mRNA水平。结果与正常组比较,模型组大鼠PPARγ、P65、IL-17 mRNA及蛋白表达水平上调(P
{"title":"[Effects of Tengmei Decoction on the PPAR-y/NF-KB Signaling Pathway in Synovium of Collagen-in- duced Arthritis Rats].","authors":"Jie Wang,&nbsp;Ya-Nan Wang,&nbsp;Yan Lu,&nbsp;Yi Chen,&nbsp;Wen Gu,&nbsp;Kang Wang,&nbsp;Zhi-Ming Shen,&nbsp;Xiang-Wei Bu,&nbsp;Hong-Hong Zhang,&nbsp;Jian-Ping Zhang,&nbsp;Qing-Yi Lu,&nbsp;Feng-Xian Meng","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Objective To observe the effects of Tengmei Decoction (TMD) on the expressions of peroxisome proliferator activated receptor gamma (PPARγ) , nuclear factor kappa B (NF-κB) , and IL- 17 in synovium of collagen-induced arthritis (CIA) rats, and to study its molecular mechanismpf. inhibi- ting synovial immune inflammatory injuries. Methods CIA model was established in Sprague-Dawley rats. Successfully modeled rats were randomly divided into the model group, the positive drug ,oup, high and low dose TMD groups, 6 in each group. Besides, a normal group was set up (n =6). Deionized water (10 mL . kg⁻¹ . d⁻¹) was administrated to rats in the normal group and the model group by gastro- gavage. Leflunomide (1. 87 mg . kg ⁻¹ . d ⁻¹) was administrated to rats in the positive drug group by gastro- gavage. TMD (31. 8 g crude drugs . kg ⁻¹ . d ⁻¹ and 15. 9 g crude drugs . kg ⁻¹ . d ⁻¹) was administrated to rats in high and low dose TMD groups respectively by gastrogavage. The intervention lasted for 12 suc- cessive weeks. Protein and mRNA levels of PPARy, P65, and IL-17 were detected at the end of intervention. Results Compared with the normal group, mRNA and protein expression levels of PPARγ, P65, and IL-17 were up-regulated in the model group (P <0. 01). Compared with the model group, PPARγ pro- tein expression level was up-regulated, mRNA and protein expression levels of P65 and IL-17 were down-regulated in high dose TMD group (P <0. 01). mRNA and protein expression levels of PPARγ were up-regulated, mRNA and protein expression levels of P65 and IL-17 were down-regulated in the positive drug group and low dose TMD group (P <0. 01). Conclusions TMD could ameliorate pathological damage of joint synovium , and inhibit expressions of immune inflammatory factors.</p>","PeriodicalId":10107,"journal":{"name":"中国中西医结合杂志","volume":"37 4","pages":"458-463"},"PeriodicalIF":0.0,"publicationDate":"2017-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36869245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Effect of Xinfeng Capsule on Beclin1/PI3K-AKT-mTOR of Adjuvant Arthritis Rats]. [心风胶囊对佐剂性关节炎大鼠Beclin1/PI3K-AKT-mTOR的影响]。
Pub Date : 2017-04-01
Ya-Li Wang, Jian Liu, Lei Wan, Li-Ping Ruan, Wen-Fang Ye

Objective To observe expression levels of autophagy related 5,7,12 mRNA (Atg5, 7,12), microtubule-associated protein 1 light chain 3 (LC3-II), Beclin1, phosphatidylinositol 3-kinase (PI3K) , protein kinase B (AKT) , mammalian target of rapamycin (mTOR) , IL-1 β, TNF-α, IL-4, and IL- 10 in adjuvant arthritis (AA) rats, and effects of Xinfeng Capsule (XFC) on them. Methods Totally 48 male SD rats were divided into 4 groups, i.e., the control group, the model group, the Western medicine (WM) group (leflunomide, 5. 0 mg/kg) , the Chinese medicine (CM) group (Xinfeng Capsule, 3.0 g/kg) , 12 in each group. Thirty days after medication body weight (BW) , toe swelling degree (E%) , arthritis in- dex (AI) , and pathological changes of ankle joint and ultrastructural changes were observed. mRNA ex- pressions of Atg5, 7, 12, protein expressions of LC3-L , Beclin1 , PI3K, AKT, mTOR, serum contents of IL-1 β, TNF-α, IL-4, and IL-10 were detected. Results Compared with the normal group, E%, Al, IL-1 β and TNF-α increased; BW, levels of IL-4 and IL-10, mRNA expressions of Atg5 and Atg12, protein ex- pressions of LC3-ll and Beclin1 decreased (P <0.01, P <0.05), protein expressions of PI3K, AKT, mTOR increased (P<0.01) in the model group. Compared with the model group, E%, Al, mRNA expres- sions of IL-1β , TNF-α-, and Atg12, protein expressions of PI3K, AKT, and mTOR decreased (P <0.01, P<0.05), IL-4, IL-10, protein expressions of LC3-II and Beclinl increased (P <0.01, P <0.05) in the two medicated groups. Atg5 mRNA expression decreased (P <0.01) , Atg7 mRNA expression increased (P < 0.05) in the WM group. Compared with the WM group,BW, IL-4, mRNA expressions of Atg5 and Atg12, protein expressions of PI3K and mTOR increased in the CM group (P <0.01 , P <0. 05). Conclusions The level of autophagy in AA rats was decreased, leading to excessive proliferation of synovial cells, swollen joints, elevated proinflammatory factors, decreased inflammatory factors, resulting in inflamma- tory reactions of joints. XFC could improve Al, toe swelling degree, and expressions of synovium autoph- agy related genes and proteins.

目的观察自噬相关5、7、12 mRNA (Atg5、7、12)、微管相关蛋白1轻链3 (LC3-II)、Beclin1、磷脂酰肌醇3-激酶(PI3K)、蛋白激酶B (AKT)、哺乳动物雷帕霉素靶蛋白(mTOR)、IL-1 β、TNF-α、IL-4、IL- 10在佐剂性关节炎(AA)大鼠中的表达水平,以及新风胶囊(XFC)对其的影响。方法48只雄性SD大鼠随机分为4组,即对照组、模型组、西药组(来氟米特、5。0 mg/kg),中药(CM)组(新风胶囊,3.0 g/kg),每组12只。用药后30 d观察大鼠体重(BW)、足趾肿胀度(E%)、关节炎指数(AI)、踝关节病理变化及超微结构变化。检测Atg5、7、12 mRNA表达,LC3-L、Beclin1、PI3K、AKT、mTOR蛋白表达,血清IL-1 β、TNF-α、IL-4、IL-10含量。结果与正常组比较,E%、Al、IL-1 β、TNF-α升高;BW、IL-4、IL-10水平、Atg5、Atg12 mRNA表达、lc3 -1、Beclin1蛋白表达降低(P < 0.05)
{"title":"[Effect of Xinfeng Capsule on Beclin1/PI3K-AKT-mTOR of Adjuvant Arthritis Rats].","authors":"Ya-Li Wang,&nbsp;Jian Liu,&nbsp;Lei Wan,&nbsp;Li-Ping Ruan,&nbsp;Wen-Fang Ye","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Objective To observe expression levels of autophagy related 5,7,12 mRNA (Atg5, 7,12), microtubule-associated protein 1 light chain 3 (LC3-II), Beclin1, phosphatidylinositol 3-kinase (PI3K) , protein kinase B (AKT) , mammalian target of rapamycin (mTOR) , IL-1 β, TNF-α, IL-4, and IL- 10 in adjuvant arthritis (AA) rats, and effects of Xinfeng Capsule (XFC) on them. Methods Totally 48 male SD rats were divided into 4 groups, i.e., the control group, the model group, the Western medicine (WM) group (leflunomide, 5. 0 mg/kg) , the Chinese medicine (CM) group (Xinfeng Capsule, 3.0 g/kg) , 12 in each group. Thirty days after medication body weight (BW) , toe swelling degree (E%) , arthritis in- dex (AI) , and pathological changes of ankle joint and ultrastructural changes were observed. mRNA ex- pressions of Atg5, 7, 12, protein expressions of LC3-L , Beclin1 , PI3K, AKT, mTOR, serum contents of IL-1 β, TNF-α, IL-4, and IL-10 were detected. Results Compared with the normal group, E%, Al, IL-1 β and TNF-α increased; BW, levels of IL-4 and IL-10, mRNA expressions of Atg5 and Atg12, protein ex- pressions of LC3-ll and Beclin1 decreased (P <0.01, P <0.05), protein expressions of PI3K, AKT, mTOR increased (P<0.01) in the model group. Compared with the model group, E%, Al, mRNA expres- sions of IL-1β , TNF-α-, and Atg12, protein expressions of PI3K, AKT, and mTOR decreased (P <0.01, P<0.05), IL-4, IL-10, protein expressions of LC3-II and Beclinl increased (P <0.01, P <0.05) in the two medicated groups. Atg5 mRNA expression decreased (P <0.01) , Atg7 mRNA expression increased (P < 0.05) in the WM group. Compared with the WM group,BW, IL-4, mRNA expressions of Atg5 and Atg12, protein expressions of PI3K and mTOR increased in the CM group (P <0.01 , P <0. 05). Conclusions The level of autophagy in AA rats was decreased, leading to excessive proliferation of synovial cells, swollen joints, elevated proinflammatory factors, decreased inflammatory factors, resulting in inflamma- tory reactions of joints. XFC could improve Al, toe swelling degree, and expressions of synovium autoph- agy related genes and proteins.</p>","PeriodicalId":10107,"journal":{"name":"中国中西医结合杂志","volume":"37 4","pages":"464-469"},"PeriodicalIF":0.0,"publicationDate":"2017-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36869246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Protection Mechanism of Alpinetin on Pulmonary Microvascular Endothelial Cells Injury]. [高血糖素对肺微血管内皮细胞损伤的保护机制]。
Pub Date : 2017-04-01
Zhen-Ran Wang, Yang Li, Bo Tang

Objective To explore the protection mechanisms about Alpinetin to acute human pulmonary microvascular endothelial cells ( HPMECs ) injury. Methods Different concentration of LPS (0. 01,0. 1 ,1. ,10 mg/L) was applied to the HPMECs to induce acute HPMECs injury. The HPMECs mod- els (n =3) were intervened by Alpinetin(40,80,160,320 mg/L) . Normal HPMECs were selected as control group. The viability of HPMECs was observed,mRNA and protein expression of intercellular cell adhesion molecule-1 (ICAM-1) ,TNF-α,APQ-1 were detected. Results Compared with control group, the protein expression of ICAM-1 , TNF-a were increased, the protein and mRNA expression of APQ-1 and the vi- ability of HPMECs were decreased in model group (P <0. 05). Compared with model group,ICAM-1 and TNF-α protein expressions were significantly inhibited in Alpinetin (80,160 mg/L) group, the mRNA and protein expression of APQ-1 and the viability of HPMECs were significantly increased (P <0. 05, P < 0. 01). Conclusion Alpenitin could protect the HPMECs injury by down-regulated protein expression of ICAM-1, TNF-α and up-regulated the mRNA and protein expression of APQ-1.

目的探讨高血糖素对急性人肺微血管内皮细胞(hpmes)损伤的保护机制。方法不同浓度的LPS(0。01, 0。1、1。剂量为10 mg/L),诱导hpmec急性损伤。用Alpinetin(40、80、160、320 mg/L)干预hpmes模型(n =3)。选取正常hpmec作为对照组。检测细胞间细胞粘附分子-1 (ICAM-1)、TNF-α、APQ-1 mRNA和蛋白的表达。结果与对照组比较,模型组细胞中ICAM-1、TNF-a蛋白表达升高,APQ-1蛋白和mRNA表达降低,hpmec细胞的vi- ability降低(P
{"title":"[Protection Mechanism of Alpinetin on Pulmonary Microvascular Endothelial Cells Injury].","authors":"Zhen-Ran Wang,&nbsp;Yang Li,&nbsp;Bo Tang","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Objective To explore the protection mechanisms about Alpinetin to acute human pulmonary microvascular endothelial cells ( HPMECs ) injury. Methods Different concentration of LPS (0. 01,0. 1 ,1. ,10 mg/L) was applied to the HPMECs to induce acute HPMECs injury. The HPMECs mod- els (n =3) were intervened by Alpinetin(40,80,160,320 mg/L) . Normal HPMECs were selected as control group. The viability of HPMECs was observed,mRNA and protein expression of intercellular cell adhesion molecule-1 (ICAM-1) ,TNF-α,APQ-1 were detected. Results Compared with control group, the protein expression of ICAM-1 , TNF-a were increased, the protein and mRNA expression of APQ-1 and the vi- ability of HPMECs were decreased in model group (P <0. 05). Compared with model group,ICAM-1 and TNF-α protein expressions were significantly inhibited in Alpinetin (80,160 mg/L) group, the mRNA and protein expression of APQ-1 and the viability of HPMECs were significantly increased (P <0. 05, P < 0. 01). Conclusion Alpenitin could protect the HPMECs injury by down-regulated protein expression of ICAM-1, TNF-α and up-regulated the mRNA and protein expression of APQ-1.</p>","PeriodicalId":10107,"journal":{"name":"中国中西医结合杂志","volume":"37 4","pages":"476-479"},"PeriodicalIF":0.0,"publicationDate":"2017-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36869247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Treatment of Mixed Hemorrhoids by RPH with the Simplified Milligan-Morgan Surgery: a Multi-center, Randomized, Controlled Clinical Trial]. [RPH +简化Milligan-Morgan手术治疗混合痔:一项多中心、随机、对照临床试验]。
Pub Date : 2017-04-01
Yong-Heng He, Zhi-Jun Tang, Xiang-Tong Xu, De-Quan Huang, Li-Shun Zhang, Qing-Zhu Tang, Zhi-Min Fan, Xian-Jun Zou, Guo-Jun Zou, Chong-Yang Zhang, Fan Hu, Biao Xie, Yan-Hua Li, Yao Tong, Hong-Chang Liu, Ke Li, Yu-Lian Luo, Fei Liu, Guang-Wei Situ, Zuo-Long Liu, Qiu-Xiang Shao

Objective To observe the safety and efficacy of RPH with the simplified. Milligan-Mor- gan(M-M) surgery on mixed hemorrhoids. Methods Totally 1 200 patients with mixed hemorrhoid were assigned to the control group(600 cases) and the treatment group(600 cases) according to randomized, parallel controlled,multi-center trial design. Patients in the control group received PPH with the simplified M-M surgery, and patients in the treatment group received RPH with the simplified M-M surgery. Postop- erative complications, operation time,the postoperative hospitalization days and the efficacy were ob- served. Results Compared with the control group, the numbers of postoperation hemorrhage, postop- erative uroschesis, anal fissure and anorectal stenosis in treatment group were decreased(P <0. 01 , P < 0. 05), operation time and the postoperative hospitalization days were decreased (P <0. 01 , P <0. 05 ), the cure rate for 3 and 12 months after operation were increased (P <0. 01, P <0. 05). Conclusions RPH with the simplified M-M surgery could reduce the incidence of postoperative complications,improve the clinical cure rate and the curative effect in treatment of mixed hemorrhoids.

目的观察简化后的RPH的安全性和有效性。混合性痔疮的M-M手术。方法采用随机、平行对照、多中心试验设计,将1 200例混合痔患者分为对照组(600例)和治疗组(600例)。对照组患者采用简化M-M手术治疗PPH,治疗组患者采用简化M-M手术治疗RPH。观察术后并发症、手术时间、住院天数及疗效。结果与对照组比较,治疗组术后出血、术后尿潴留、肛裂、肛肠狭窄发生率明显降低(P
{"title":"[Treatment of Mixed Hemorrhoids by RPH with the Simplified Milligan-Morgan Surgery: a Multi-center, Randomized, Controlled Clinical Trial].","authors":"Yong-Heng He,&nbsp;Zhi-Jun Tang,&nbsp;Xiang-Tong Xu,&nbsp;De-Quan Huang,&nbsp;Li-Shun Zhang,&nbsp;Qing-Zhu Tang,&nbsp;Zhi-Min Fan,&nbsp;Xian-Jun Zou,&nbsp;Guo-Jun Zou,&nbsp;Chong-Yang Zhang,&nbsp;Fan Hu,&nbsp;Biao Xie,&nbsp;Yan-Hua Li,&nbsp;Yao Tong,&nbsp;Hong-Chang Liu,&nbsp;Ke Li,&nbsp;Yu-Lian Luo,&nbsp;Fei Liu,&nbsp;Guang-Wei Situ,&nbsp;Zuo-Long Liu,&nbsp;Qiu-Xiang Shao","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Objective To observe the safety and efficacy of RPH with the simplified. Milligan-Mor- gan(M-M) surgery on mixed hemorrhoids. Methods Totally 1 200 patients with mixed hemorrhoid were assigned to the control group(600 cases) and the treatment group(600 cases) according to randomized, parallel controlled,multi-center trial design. Patients in the control group received PPH with the simplified M-M surgery, and patients in the treatment group received RPH with the simplified M-M surgery. Postop- erative complications, operation time,the postoperative hospitalization days and the efficacy were ob- served. Results Compared with the control group, the numbers of postoperation hemorrhage, postop- erative uroschesis, anal fissure and anorectal stenosis in treatment group were decreased(P <0. 01 , P < 0. 05), operation time and the postoperative hospitalization days were decreased (P <0. 01 , P <0. 05 ), the cure rate for 3 and 12 months after operation were increased (P <0. 01, P <0. 05). Conclusions RPH with the simplified M-M surgery could reduce the incidence of postoperative complications,improve the clinical cure rate and the curative effect in treatment of mixed hemorrhoids.</p>","PeriodicalId":10107,"journal":{"name":"中国中西医结合杂志","volume":"37 4","pages":"422-425"},"PeriodicalIF":0.0,"publicationDate":"2017-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36913612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Correlation Research on HGF and c-Met of Chronic Erosive Gastritis Patients]. 慢性糜烂性胃炎患者HGF与c-Met的相关性研究
Pub Date : 2017-04-01
Yan-Gang Wang, Jing-Jing Lv, Huan Dong, Pan-Pan Zhou

Objective To observe the correlation of hepatocyte growth factor (HGF) and Hepato- cyte growth factor receptor (c-Met ) in serum and gastric mucosa tissues of chronic erosive gastritis pa- tients. Methods Totally 70 patients with chronic erosive gastritis were selected and assigned to turbidity toxin intrinsic syndrome group and Gan-wei disharmony syndrome group, HGF expression level of ser- um,and HGF,c-Met expression level of gastric mucosa tissues were measured;the correlation of HGF and c-Met in gastric mucosa tissues, and the correlation of HGF in serum and gastric mucosa tissues were analyzed. Results The expression level of HGF and c-Met in turbidity toxin intrinsic syndrome group was higher than that in Gan-wei disharmony syndrome group (P <0. 05) ; the expression level of HGF in gastric mucosa tissues was positively correlated with c-Met(r =0. 831 , P <0. 05) ; the expression level of HGF in serum was positively correlated with that of gastric mucosa tissues(r =0. 656, P <0. 05). Conclusions There was correlation between turbidity toxin intrinsic syndrome of Chronic Erosive Gastri- tis patients and the expression level of HGF and c-Met.

目的观察慢性糜烂性胃炎患者血清和胃黏膜组织中肝细胞生长因子(HGF)和肝细胞生长因子受体(c-Met)的相关性。方法选择70例慢性糜烂性胃炎患者,分为浊毒内证组和甘味不和证组,测定血清HGF表达水平,胃黏膜组织HGF、c-Met表达水平,分析胃黏膜组织HGF、c-Met的相关性,以及血清与胃黏膜组织HGF的相关性。结果浊毒内证组HGF、c-Met表达水平高于肝胃不和证组(P
{"title":"[Correlation Research on HGF and c-Met of Chronic Erosive Gastritis Patients].","authors":"Yan-Gang Wang,&nbsp;Jing-Jing Lv,&nbsp;Huan Dong,&nbsp;Pan-Pan Zhou","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Objective To observe the correlation of hepatocyte growth factor (HGF) and Hepato- cyte growth factor receptor (c-Met ) in serum and gastric mucosa tissues of chronic erosive gastritis pa- tients. Methods Totally 70 patients with chronic erosive gastritis were selected and assigned to turbidity toxin intrinsic syndrome group and Gan-wei disharmony syndrome group, HGF expression level of ser- um,and HGF,c-Met expression level of gastric mucosa tissues were measured;the correlation of HGF and c-Met in gastric mucosa tissues, and the correlation of HGF in serum and gastric mucosa tissues were analyzed. Results The expression level of HGF and c-Met in turbidity toxin intrinsic syndrome group was higher than that in Gan-wei disharmony syndrome group (P <0. 05) ; the expression level of HGF in gastric mucosa tissues was positively correlated with c-Met(r =0. 831 , P <0. 05) ; the expression level of HGF in serum was positively correlated with that of gastric mucosa tissues(r =0. 656, P <0. 05). Conclusions There was correlation between turbidity toxin intrinsic syndrome of Chronic Erosive Gastri- tis patients and the expression level of HGF and c-Met.</p>","PeriodicalId":10107,"journal":{"name":"中国中西医结合杂志","volume":"37 4","pages":"410-413"},"PeriodicalIF":0.0,"publicationDate":"2017-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36913610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Integrated Traditional Chinese and Western Medicine Will be the Mainstream Medicine of China]. 【中西医结合将成为中国的主流医学】。
Pub Date : 2017-04-01
Yuan Yang, Shu-de Yang

The coexist of Chinese Medicine, Western Medicine and the Integrated Traditional Chinese and Western Medicine is the transitional period in long medical progress. They will eventually become a rela- tively consummate medicine modality-Integrated Traditional Chinese and Western Medicine. It's the inherit- ance, innovation and development which includes the advantages and essence of the other two Medicine, and will be the mainstream in the field of Medicine of China.

中西医和中西医结合并存是医学发展史上的一个过渡时期。它们最终将形成一种相对完善的医学模式——中西医结合。它是对其他两种医学的优点和精华的继承、创新和发展,将成为中国医学领域的主流。
{"title":"[Integrated Traditional Chinese and Western Medicine Will be the Mainstream Medicine of China].","authors":"Yuan Yang,&nbsp;Shu-de Yang","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The coexist of Chinese Medicine, Western Medicine and the Integrated Traditional Chinese and Western Medicine is the transitional period in long medical progress. They will eventually become a rela- tively consummate medicine modality-Integrated Traditional Chinese and Western Medicine. It's the inherit- ance, innovation and development which includes the advantages and essence of the other two Medicine, and will be the mainstream in the field of Medicine of China.</p>","PeriodicalId":10107,"journal":{"name":"中国中西医结合杂志","volume":"37 4","pages":"490-491"},"PeriodicalIF":0.0,"publicationDate":"2017-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36869669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Three Waves of Arsenic Therapy for Leukemia and Related Innovations]. [三波砷治疗白血病及相关创新]。
Pub Date : 2017-04-01
Yong-Ming Li

There were three waves of arsenic therapy for leukemia in the history and every time, it started with a particular medical innovation. German doctor first found that Fowler arsenic solution might improve symptoms of leukemia patients in 1865 but the therapy was never popular due to uncertainty. In 1931, American hematologists reported a series of chronic myeloid leukemia cases successfully managed by arsenic solutions , and published the pathological data supporting the specificity of arsenic action on leu- kemic cells. Not until late 1970s, after the publication of new FAB classification of leukemia, Chinese doctors from Harbin Medical University who had been exploring novel applications of traditional Chinese medi- cines, discovered that the new leukemic entity, acute promyelocytic leukemia (APL) was the best indica- tion for arsenic containing remedy. The theory was supported by many APL survivors and later trials with As₂Ο₃, as a monotherapy. The Harbin Protocol was soon repeated successful in China and in the West, and As₂Ο₃, became a FDA approved new drug for APL in 2001. The discovery of arsenic therapy for APL was ap- parently not an incidental finding, but a timely advance following medical innovation. The continuing efforts in the research of traditional Chinese medicine and the teamwork of specialists in Chinese medicine, hema- tology, pathology, and pharmacology made this innovative discovery possible.

历史上有三次砷治疗白血病的浪潮,每一次,它都以一种特殊的医学创新开始。1865年,一位德国医生首次发现福勒砷溶液可以改善白血病患者的症状,但由于不确定性,这种疗法从未普及。1931年,美国血液学家报道了一系列用砷溶液成功治疗的慢性髓系白血病病例,并发表了支持砷对白血病细胞特异性作用的病理资料。直到20世纪70年代末,在白血病FAB新分类发表后,一直在探索中药新应用的哈尔滨医科大学的中国医生才发现,急性早幼粒细胞白血病(APL)这一新的白血病实体是含砷治疗的最佳适应症。这一理论得到了许多APL幸存者的支持,后来用As₂Ο₃作为一种单一疗法进行了试验。哈尔滨议定书很快在中国和西方国家获得了成功,2001年,As₂Ο₃被美国食品药品管理局(FDA)批准为APL新药。砷治疗APL的发现显然不是偶然发现,而是医学创新后的及时进展。中医研究的持续努力和中医、血液学、病理学和药理学专家的团队合作,使这一创新发现成为可能。
{"title":"[Three Waves of Arsenic Therapy for Leukemia and Related Innovations].","authors":"Yong-Ming Li","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>There were three waves of arsenic therapy for leukemia in the history and every time, it started with a particular medical innovation. German doctor first found that Fowler arsenic solution might improve symptoms of leukemia patients in 1865 but the therapy was never popular due to uncertainty. In 1931, American hematologists reported a series of chronic myeloid leukemia cases successfully managed by arsenic solutions , and published the pathological data supporting the specificity of arsenic action on leu- kemic cells. Not until late 1970s, after the publication of new FAB classification of leukemia, Chinese doctors from Harbin Medical University who had been exploring novel applications of traditional Chinese medi- cines, discovered that the new leukemic entity, acute promyelocytic leukemia (APL) was the best indica- tion for arsenic containing remedy. The theory was supported by many APL survivors and later trials with As₂Ο₃, as a monotherapy. The Harbin Protocol was soon repeated successful in China and in the West, and As₂Ο₃, became a FDA approved new drug for APL in 2001. The discovery of arsenic therapy for APL was ap- parently not an incidental finding, but a timely advance following medical innovation. The continuing efforts in the research of traditional Chinese medicine and the teamwork of specialists in Chinese medicine, hema- tology, pathology, and pharmacology made this innovative discovery possible.</p>","PeriodicalId":10107,"journal":{"name":"中国中西医结合杂志","volume":"37 4","pages":"401-405"},"PeriodicalIF":0.0,"publicationDate":"2017-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36859080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Effect of Electroacupuncture on ATP-sensitive Potassium Channel and Protein Kinase mRNA Ex- pression in Myocardial Ischemia Model Rats]. 电针对心肌缺血模型大鼠atp敏感钾通道及蛋白激酶mRNA表达的影响。
Pub Date : 2017-04-01
Wei Wang, Ji-Quan Li, Xiang-Yu Meng, Yi-Guo Chen, Qin Jing

Objective To observe the effect of electroacupuncture (EA) at different acupoints on mRNA expressions of ATP-sensitive potassium channel (Kir6. 1, Kir6. 2) and conjugated protein (SUR2A, SUR2B) and protein kinases (PKA, PKG and PKC132) in myocardial ischemia model rats. Methods Myocardial ischemia model was established in healthy male SD rats via subcutaneously injec- ting ISO (85 mg/kg) multipointedly (medial root of limbs and the back). Then they were randomly divided into 4 groups, i.e., the model group, Neiguan (PC6) group, Lieque (LU7) group, non-acupoint group, 10 in each group. Besides, another 10 healthy rats were recruited as the control group. Corresponding EA was performed at respective acupoints to rats in Neiguan (PC6) group, Lieque (LU7) group, non-acu- point group, with dense-sparse wave, 2 -3 mA, 2 -20 Hz, needle retaining time of 20 min, once per day for 7 successive days. mRNA expression levels of Kir6. 1 and Kir6. 2, SUR2A, SUR2B, PKA, PKG, and PKCβ₂ in left ventricular myocardium were analyzed by Real-time PCR. Results Compared with the con- trol group, mRNA expressions of each index increased in the model group (P <0. 01). Compared with the model group, mRNA expressions of each index significantly decreased in Neiguan (PC6) group and Lieque (LU7) group (P<0. 01). Compared with Neiguan (PC6) group, mRNA expressions of each index significantly increased in Lieque (LU7) group and non-acupoint group (P <0. 01). Compared with Lieque (LU7) group, mRNA expressions of each index significantly increased in non-acupoint group (P <0. 05). Conclusion EA at Neiguan (PC6) could reverse mRNA expression changes of ATP-sensitive potassium channel (Kir6. 1 and Kir6. 2)and conjugated proteins (SUR2A and SUR2B) and protein kinases (PKA, PKG, and PKCβ₂).

目的观察电针(EA)不同穴位对atp敏感钾通道(Kir6) mRNA表达的影响。1, Kir6。2)和偶联蛋白(SUR2A、SUR2B)和蛋白激酶(PKA、PKG、PKC132)在心肌缺血模型大鼠中的表达。方法健康雄性SD大鼠多点皮下注射ISO (85 mg/kg)(四肢内侧根和背部),建立心肌缺血模型。然后随机分为模型组、内关(PC6)组、利克(LU7)组、无穴组4组,每组10只。另取健康大鼠10只作为对照组。内关(PC6)组、利克(LU7)组、非穴位组大鼠分别在相应穴位行电针,波密稀疏,2 -3 mA, 2 -20 Hz,持针时间20 min,每天1次,连续7 d。Kir6的mRNA表达水平。1和Kir6。Real-time PCR检测左心室心肌2、SUR2A、SUR2B、PKA、PKG、PKCβ 2。结果与对照组比较,模型组大鼠各指标mRNA表达均升高(P
{"title":"[Effect of Electroacupuncture on ATP-sensitive Potassium Channel and Protein Kinase mRNA Ex- pression in Myocardial Ischemia Model Rats].","authors":"Wei Wang,&nbsp;Ji-Quan Li,&nbsp;Xiang-Yu Meng,&nbsp;Yi-Guo Chen,&nbsp;Qin Jing","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Objective To observe the effect of electroacupuncture (EA) at different acupoints on mRNA expressions of ATP-sensitive potassium channel (Kir6. 1, Kir6. 2) and conjugated protein (SUR2A, SUR2B) and protein kinases (PKA, PKG and PKC132) in myocardial ischemia model rats. Methods Myocardial ischemia model was established in healthy male SD rats via subcutaneously injec- ting ISO (85 mg/kg) multipointedly (medial root of limbs and the back). Then they were randomly divided into 4 groups, i.e., the model group, Neiguan (PC6) group, Lieque (LU7) group, non-acupoint group, 10 in each group. Besides, another 10 healthy rats were recruited as the control group. Corresponding EA was performed at respective acupoints to rats in Neiguan (PC6) group, Lieque (LU7) group, non-acu- point group, with dense-sparse wave, 2 -3 mA, 2 -20 Hz, needle retaining time of 20 min, once per day for 7 successive days. mRNA expression levels of Kir6. 1 and Kir6. 2, SUR2A, SUR2B, PKA, PKG, and PKCβ₂ in left ventricular myocardium were analyzed by Real-time PCR. Results Compared with the con- trol group, mRNA expressions of each index increased in the model group (P <0. 01). Compared with the model group, mRNA expressions of each index significantly decreased in Neiguan (PC6) group and Lieque (LU7) group (P<0. 01). Compared with Neiguan (PC6) group, mRNA expressions of each index significantly increased in Lieque (LU7) group and non-acupoint group (P <0. 01). Compared with Lieque (LU7) group, mRNA expressions of each index significantly increased in non-acupoint group (P <0. 05). Conclusion EA at Neiguan (PC6) could reverse mRNA expression changes of ATP-sensitive potassium channel (Kir6. 1 and Kir6. 2)and conjugated proteins (SUR2A and SUR2B) and protein kinases (PKA, PKG, and PKCβ₂).</p>","PeriodicalId":10107,"journal":{"name":"中国中西医结合杂志","volume":"37 4","pages":"448-452"},"PeriodicalIF":0.0,"publicationDate":"2017-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36869242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Serum Proteomic Analysis and Construction of Protein-protein Interaction Networks about Ejaculation Praecox with Shen-yang Deficiency]. 阳虚早泄患者血清蛋白质组学分析及蛋白相互作用网络的构建[j]。
Pub Date : 2017-04-01
Cong-E Tan, Xiang-Yun Huang, Mi-Qu Wang

Objective To identify serum proteome of ejaculation praecox(EP) with Shen-yang de- ficiency, and to explore its pathogenesis of EP in the protein-protein interaction ( PPI) network. Methods The serum samples were respectively collected from 4 EP with Shen-yang deficiency patients and 4 healthy controls. After the serum proteome of EP with Shen-yang deficiency was obtained, the technology of isobaric tags for relative and absolute quantitation (iTRAQ) was adopted for identification. The STRING data- base was applied to construct the PPI network whose function was analyzed through bioinformatics meth- ods. Results A group of 238 serum proteins were identified in total, of which, 162 proteins reached the strict quantitative standard. Nine proteins were differently expressed, including 1 up-regulated and 8 down-regulated. The constructed PPI network was constituted by 72 protein nodes and 283 protein couples, and could be clustered to 16 clusters, in which 10 clusters were composed of 3 or more proteins. Each cluster could be found with a core protein correspondingly. The core protein of C3,C5,C1S and MASP2 were all main constituents of complement system, whose function involves in biological process of complement ac- tivation. Conclusions The protein models in PPI network of differently expressed serum proteome about EP with Shen-yang deficiency were functional enriched in the biological process of complement activa-, tion; which indicate that a immune dysfuction dominated by abnormal process of complent activation may' be one of the main mechanisms of EP with Shen-yang deficiency.

目的鉴定阳虚早泄(EP)患者血清蛋白质组,探讨EP在蛋白-蛋白相互作用(PPI)网络中的发病机制。方法分别采集4例EP阳虚患者和4例健康对照者的血清。获得阳虚EP血清蛋白质组后,采用等压标签相对绝对定量(iTRAQ)技术进行鉴定。应用STRING数据库构建PPI网络,并利用生物信息学方法对其功能进行分析。结果共鉴定出238种血清蛋白,其中162种达到严格的定量标准。9个蛋白不同表达,其中上调1个,下调8个。构建的PPI网络由72个蛋白质节点和283对蛋白质对组成,可聚为16个簇,其中10个簇由3个或3个以上蛋白质组成。每个簇对应一个核心蛋白。C3、C5、C1S和MASP2等核心蛋白都是补体系统的主要组成部分,其功能涉及补体活化的生物学过程。结论阳虚EP不同表达血清蛋白质组的PPI网络蛋白模型在补体激活生物学过程中功能富集;提示以补体活化异常过程为主的免疫功能障碍可能是阳虚EP的主要机制之一。
{"title":"[Serum Proteomic Analysis and Construction of Protein-protein Interaction Networks about Ejaculation Praecox with Shen-yang Deficiency].","authors":"Cong-E Tan,&nbsp;Xiang-Yun Huang,&nbsp;Mi-Qu Wang","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Objective To identify serum proteome of ejaculation praecox(EP) with Shen-yang de- ficiency, and to explore its pathogenesis of EP in the protein-protein interaction ( PPI) network. Methods The serum samples were respectively collected from 4 EP with Shen-yang deficiency patients and 4 healthy controls. After the serum proteome of EP with Shen-yang deficiency was obtained, the technology of isobaric tags for relative and absolute quantitation (iTRAQ) was adopted for identification. The STRING data- base was applied to construct the PPI network whose function was analyzed through bioinformatics meth- ods. Results A group of 238 serum proteins were identified in total, of which, 162 proteins reached the strict quantitative standard. Nine proteins were differently expressed, including 1 up-regulated and 8 down-regulated. The constructed PPI network was constituted by 72 protein nodes and 283 protein couples, and could be clustered to 16 clusters, in which 10 clusters were composed of 3 or more proteins. Each cluster could be found with a core protein correspondingly. The core protein of C3,C5,C1S and MASP2 were all main constituents of complement system, whose function involves in biological process of complement ac- tivation. Conclusions The protein models in PPI network of differently expressed serum proteome about EP with Shen-yang deficiency were functional enriched in the biological process of complement activa-, tion; which indicate that a immune dysfuction dominated by abnormal process of complent activation may' be one of the main mechanisms of EP with Shen-yang deficiency.</p>","PeriodicalId":10107,"journal":{"name":"中国中西医结合杂志","volume":"37 4","pages":"438-442"},"PeriodicalIF":0.0,"publicationDate":"2017-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36913617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中国中西医结合杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1